Summary

Antibody drugs are ultimately used in the human body, inevitably facing the problem of humanization, so it is very important to obtain recombinant antibodies which are safe, stable and close to nature. Recombinant antibody expression technology makes the preparation of humanized antibodies come into being.

We have been providing high quality recombinant antibodies to support a variety of applications in drug discovery research, including high throughput screening (HTS), in vitro activity and functional assays, in vivo animal studies

Our Advantages

1.Zhong Ding has a mature experimental platform for recombinant protein expression and antibody preparation technology platform, which can achieve seamless experiment docking, make project integration, process homogenization possible, and ensure the timeliness and quality.

2.The abundant resources of antibody expression vectors make our antibody expression services even more useful. We only need to provide heavy chain and light chain variable region sequences and subclone them into specific expression vectors to start the expression project. Most importantly, we offer it free of charge.

3.Mature sequencing optimization technology, combined with HEK293 improved cell line, can maximize the expression potential. The yield of conventional instantaneous transfection is 10-100 mg/L. High yield of small-scale transfection is conducive to cost savings and commercial application potential.

case

      case                  case

    detection results of purified antibodies by electrophoresis
    (reduced)SDS-PAGE
    Lane M:Marker
    Lane 1-4 recombinant antibody solutions with different elution
    concentrations were collected.
  
    detection results of purified antibodies by electrophoresis
    (reduced)SDS-PAGE
    Lane M:Marker
    Lane 1-3 recombinant antibody solutions with different elution
    concentrations were collected.


Related services:

custom matched monoclonal antibody service

western blotting service

immunohistochemistry(IHC) testing services